PTHS · Pelthos Therapeutics Inc
United States · RS rating 6 · As of 2026-11-03
| Price | 10.78 USD |
|---|---|
| 1-day change | -6.4% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 5 / 5 / 13 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 28 / 5 / 13 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -29.6% |
| Sales growth Q/Q | +26.8% |
| Distance from 52-week high | +71.2% |
| Market cap (USD) | $77.8M |